Martin Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.79M | Hold |
14,139
| – | – | 1.16% | 25 |
|
|
2025
Q1 | $1.81M | Sell |
14,139
-300
| -2% | -$38.4K | 1.29% | 22 |
|
|
2024
Q4 | $1.91M | Buy |
14,439
+1,270
| +10% | +$168K | 1.23% | 23 |
|
|
2024
Q3 | $1.92M | Buy |
13,169
+133
| +1% | +$19.4K | 1.37% | 21 |
|
|
2024
Q2 | $1.79M | Sell |
13,036
-158
| -1% | -$21.7K | 1.34% | 24 |
|
|
2024
Q1 | $1.81M | Sell |
13,194
-180
| -1% | -$24.7K | 1.42% | 23 |
|
|
2023
Q4 | $1.82M | Sell |
13,374
-96
| -0.7% | -$13K | 1.53% | 21 |
|
|
2023
Q3 | $1.65M | Buy |
13,470
+249
| +2% | +$30.5K | 1.6% | 19 |
|
|
2023
Q2 | $1.68M | Buy |
13,221
+230
| +2% | +$29.2K | 1.54% | 20 |
|
|
2023
Q1 | $1.68M | Sell |
12,991
-995
| -7% | -$129K | 1.73% | 15 |
|
|
2022
Q4 | $1.84M | Buy |
13,986
+2,513
| +22% | +$330K | 2.05% | 14 |
|
|
2022
Q3 | $1.34M | Sell |
11,473
-7,424
| -39% | -$868K | 1.97% | 15 |
|
|
2022
Q2 | $2.22M | Buy |
18,897
+105
| +0.6% | +$12.4K | 1.96% | 15 |
|
|
2022
Q1 | $2.45M | Buy |
18,792
+340
| +2% | +$44.3K | 1.68% | 17 |
|
|
2021
Q4 | $2.82M | Buy |
+18,452
| New | +$2.82M | 1.74% | 16 |
|